To ensure sustainable growth, and to realize our long-term strategic vision of developing Santen into a specialized pharmaceutical company with global presence, we are committed to the protection and improvement of eyesight and the health of patients. Focusing our efforts on the ophthalmic field Santen hopes to advance treatments by delivering innovative products and services to patients and medical professionals worldwide.To realize this long-term strategic vision, we are strengthening our pipeline of compounds for development, building a global clinical development system, and investing in the development of new businesses in the rapidly growing markets in Europe and Asia, as well as in Japan, where we can best maximize our strengths.Santen hopes to help many more people enjoy looking at various objects and scenes, particularly delightful scenes.As a specialized pharmaceutical company primarily engaged in the ophthalmic field, Santen has established a paramount position in Japan's prescription ophthalmic pharmaceutical market and has expanded into the global market.Santen will continue its dedication to improving the eyesight and health of people worldwide, exercising the spirit of creation and innovation, as well as the scientific knowledge and organizational capabilities that we have nurtured for over 120 years since the founding of our Company.
To ensure sustainable growth, and to realize our long-term strategic vision of developing Santen into a specialized pharmaceutical company with global presence, we are committed to the protection and improvement of eyesight and the health of patients. Focusing our efforts on the ophthalmic field Santen hopes to advance treatments by delivering innovative products and services to patients and medical professionals worldwide.To realize this long-term strategic vision, we are strengthening our pipeline of compounds for development, building a global clinical development system, and investing in the development of new businesses in the rapidly growing markets in Europe and Asia, as well as in Japan, where we can best maximize our strengths.Santen hopes to help many more people enjoy looking at various objects and scenes, particularly delightful scenes.As a specialized pharmaceutical company primarily engaged in the ophthalmic field, Santen has established a paramount position in Japan's prescription ophthalmic pharmaceutical market and has expanded into the global market.Santen will continue its dedication to improving the eyesight and health of people worldwide, exercising the spirit of creation and innovation, as well as the scientific knowledge and organizational capabilities that we have nurtured for over 120 years since the founding of our Company.
To ensure sustainable growth, and to realize our long-term strategic vision of developing Santen into a specialized pharmaceutical company with global presence, we are committed to the protection and improvement of eyesight and the health of patients. Focusing our efforts on the ophthalmic field Santen hopes to advance treatments by delivering innovative products and services to patients and medical professionals worldwide.To realize this long-term strategic vision, we are strengthening our pipeline of compounds for development, building a global clinical development system, and investing in the development of new businesses in the rapidly growing markets in Europe and Asia, as well as in Japan, where we can best maximize our strengths.Santen hopes to help many more people enjoy looking at various objects and scenes, particularly delightful scenes.As a specialized pharmaceutical company primarily engaged in the ophthalmic field, Santen has established a paramount position in Japan's prescription ophthalmic pharmaceutical market and has expanded into the global market.Santen will continue its dedication to improving the eyesight and health of people worldwide, exercising the spirit of creation and innovation, as well as the scientific knowledge and organizational capabilities that we have nurtured for over 120 years since the founding of our Company.